Literature DB >> 3198564

MAOIs in adolescent major depression unresponsive to tricyclic antidepressants.

N D Ryan, J Puig-Antich, H Rabinovich, J Fried, P Ambrosini, V Meyer, D Torres, S Dachille, D Mazzie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3198564     DOI： 10.1097/00004583-198811000-00016

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN： 0890-8567            Impact factor:   8.829


× No keyword cloud information.
  7 in total

Review 1.  Pharmacological treatment of depression in children and adolescents.

Authors:  R L Findling; M D Reed; J L Blumer
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

Review 2.  Depression in childhood. 1. Drugs may be useful.

Authors:  C A Kaplan
Journal:  BMJ       Date:  1990-05-12

Review 3.  A risk-benefit assessment of pharmacotherapies for clinical depression in children and adolescents.

Authors:  J Renaud; D Axelson; B Birmaher
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

Review 4.  Psychopharmacologic treatment of pediatric major depressive disorder.

Authors:  Khrista Boylan; Soledad Romero; Boris Birmaher
Journal:  Psychopharmacology (Berl)       Date:  2006-08-08       Impact factor: 4.530

5.  Efficacy of antidepressants in child and adolescent depression: a meta-analytic study.

Authors:  K Papanikolaou; C Richardson; A Pehlivanidis; Z Papadopoulou-Daifoti
Journal:  J Neural Transm (Vienna)       Date:  2005-08-03       Impact factor: 3.575

6.  The effect of adjunctive light therapy on ameliorating breakthrough depressive symptoms in adolescent-onset bipolar disorder.

Authors:  G Papatheodorou; S Kutcher
Journal:  J Psychiatry Neurosci       Date:  1995-05       Impact factor: 6.186

7.  Major Depressive Disorder and Kappa Opioid Receptor Antagonists.

Authors:  Wei Li; Huijiao Sun; Hao Chen; Xicheng Yang; Li Xiao; Renyu Liu; Liming Shao; Zhuibai Qiu
Journal:  Transl Perioper Pain Med       Date:  2016
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.